Gábor Holló. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Administration, TopicalAdrenergic beta-Antagonists/pharmacokineticsAdrenergic beta-Antagonists/therapeutic useBetaxolol/pharmacokineticsBetaxolol/therapeutic useEye/metabolismGlaucoma/prevention & controlHumansNeuroprotective Agents/administration & dosageNeuroprotective Agents/pharmacokineticsNeuroprotective Agents/therapeutic use
Substances: See more » Adrenergic beta-AntagonistsNeuroprotective AgentsBetaxolol
Year: 2007 PMID: 17927292 DOI: 10.2165/00003495-200767150-00014
Source DB: PubMed Journal: Drugs ISSN: 0012-6667 Impact factor: 9.546